The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) released its first program-level data for Fiscal Year 2025 in April 2026, offering insight into HIV service delivery amid significant operational changes. The Monitoring, Evaluation, and Reporting (MER) data for the fourth quarter of FY 2025—covering July 1 to September 30, 2025—was made public on April 17, 2026, marking the first such release since major disruptions began in early 2025. This data provides a critical snapshot of PEPFAR-supported activities during a period of transition following administrative reviews and funding adjustments.
According to the U.S. Department of State’s Bureau of Global Health Security and Diplomacy, the FY 2025 Q4 MER release shows that PEPFAR continues to support over 20 million people living with HIV across its partner countries. The data also indicates that the number of pregnant and breastfeeding women receiving antiretroviral therapy to prevent mother-to-child transmission of HIV more than doubled compared to previous reporting periods. These figures underscore the sustained reach of PEPFAR-funded programs despite challenges in data reporting and implementation during the fiscal year.
The release represents a resumption of transparency after PEPFAR’s flagship data platform was temporarily removed in early 2025 and, upon restoration, did not include any program data from FY 2025. The State Department attributed the absence of data for quarters one through three of FY 2025 to reporting and implementation challenges stemming from organizational changes, including the launch of a new “America First Global Health Strategy” and shifts toward bilateral agreements and integrated service delivery models.
PEPFAR, launched in 2003, remains the largest commitment by any nation to combat a single disease in history. To date, more than $55.75 billion has been programmed through bilateral investments in partner countries. The program has been credited with saving over 26 million lives since its inception, according to longstanding estimates cited in multiple official analyses.
The Monitoring, Evaluation, and Reporting (MER) system, launched more than a decade ago, has historically provided financial and program-level results, including district- and facility-level data through PEPFAR’s own data platform. The amfAR-developed PEPFAR MER Database complements official releases by offering civil society organizations a tool to explore impacts across 36 country and regional programs where PEPFAR operates.
Stakeholders including governments, implementing partners, and advocacy groups rely on MER data to assess progress toward epidemic control, allocate resources, and identify gaps in service delivery. The FY 2025 Q4 release is particularly significant as it offers the first verifiable measure of PEPFAR’s output under revised operational frameworks that emphasize frontline commodities, bilateral engagement, and integration with broader health systems.
While the data confirms continued support for core HIV prevention and treatment services, experts note that the absence of quarterly data for the first nine months of FY 2025 limits year-over-year trend analysis and comprehensive performance evaluation. Independent observers have called for the resumption of regular, timely MER releases to ensure accountability and enable real-time program adjustments.
The next scheduled update to PEPFAR’s public MER data has not been officially announced. Readers seeking official information can access the latest releases through the U.S. Department of State’s Bureau of Global Health Security and Diplomacy website or the amfAR PEPFAR MER Database, both of which provide verified, authoritative sources for tracking program outcomes.
As global health initiatives continue to evolve, transparent and consistent data reporting remains essential for maintaining public trust, guiding policy decisions, and sustaining progress against HIV/AIDS. The FY 2025 Q4 MER release serves as both a benchmark and a reminder of the importance of uninterrupted monitoring in long-term public health efforts.
If you found this analysis informative, please consider sharing it with others interested in global health policy or leaving a comment below to join the conversation.
Keep reading
- Medidata Launches Medidata Plus AI Layer to Standardize Clinical Trial Data and Workflows
- Voici combien de cafés vous pouvez boire quotidiennement, selon un urgentologue – QUB radio
- Alex Mariah Peter Reveals 30-Kilogram Weight Loss Transformation (archyworldys.com)
- COVID-19 Impact on Cesarean Section Rates: A Robson Classification Analysis (archynewsy.com)